$Billions of fraud in HHS programs

The Department of Health and Human Services Office of Inspector General (OIG) will recover more than $2 billion through audits and investigations of fraud, waste and abuse in HHS programs, the office linkurl:announced;http://www.oig.hhs.gov/publications/docs/press/2008/semiannual_press_spring2008.pdf last Thursday (Jun 12). "OIG's accomplishments reflect a robust oversight agenda implemented through audits, evaluations, and compliance and enforcement activities," said Inspector General linkurl:

Written byBob Grant
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share
The Department of Health and Human Services Office of Inspector General (OIG) will recover more than $2 billion through audits and investigations of fraud, waste and abuse in HHS programs, the office linkurl:announced;http://www.oig.hhs.gov/publications/docs/press/2008/semiannual_press_spring2008.pdf last Thursday (Jun 12). "OIG's accomplishments reflect a robust oversight agenda implemented through audits, evaluations, and compliance and enforcement activities," said Inspector General linkurl:Daniel Levinson;http://www.oig.hhs.gov/organization/IGbiography.html in an OIG press release. "It is through a combination of vigilant oversight, outreach to the health care community, and partnership with government agencies at all levels that we are able to fulfill our mission to protect the integrity of HHS programs and beneficiaries." A couple of the incidents outlined in OIG's linkurl:"Semiannual Report to Congress,";http://www.oig.hhs.gov/publications/docs/semiannual/2008/semiannual_spring2008.pdf which outlines the body's plans to recover a total of $2.2 billion through the first half of FY 2008, involve the National Institutes of Health. These included $11.8 million in mis-procured funds that the NIH acquired from the linkurl:Department of Defense;http://www.the-scientist.com/article/display/43635/ (DOD) between 2002 and 2006 but charged to the wrong appropriation category. The OIG also found that "NIH did not always maintain adequate documentation with respect to acquisition planning, competition, award decisions, and contractor monitoring" when procuring funds from the DOD. Also contributing to the OIG's $2.2 billion total were $24,221 recovered from Charrisse Fairfax-Brown, a former NIH employee who was convicted to 45 days in prison for stealing government property and using a government credit card for unauthorized purchases, such as shoes, clothes, jewelry, a laptop computer, and cable TV service. The OIG report also states that the NIH needs to resolve problems with its oversight of conflicts of interest among its linkurl:extramural researchers.;http://www.the-scientist.com/news/display/53048/ Between 2004 and 2006, the NIH could not provide OIG an accurate count of the financial conflicts of interest reports that it received from grantees, according to the report. The OIG also found that about 89 percent of the 438 financial conflicts of interest reports received from NIH grantee institutions in 2006, did not state the nature of the conflicts or the way in which they would be managed.
Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here
Add The Scientist as a preferred source on Google

Add The Scientist as a preferred Google source to see more of our trusted coverage.

Meet the Author

  • From 2017 to 2022, Bob Grant was Editor in Chief of The Scientist, where he started in 2007 as a Staff Writer. Before joining the team, he worked as a reporter at Audubon and earned a master’s degree in science journalism from New York University. In his previous life, he pursued a career in science, getting a bachelor’s degree in wildlife biology from Montana State University and a master’s degree in marine biology from the College of Charleston in South Carolina. Bob edited Reading Frames and other sections of the magazine.

    View Full Profile
Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Graphic of amino acid chains folded into proteins

Expi293™ PRO Expression System: Higher Yields Across a Wider Variety of Proteins

Thermo Fisher Logo